How to detect a dwarf: In vivo imaging of nanoparticles in the lung

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 7, Issue 6, 2011, Pages 753-762

  Roller, Jonas ^a,b   Laschke, Matthias W ^a   Tschernig, Thomas ^a   Schramm, René ^c   Veith, Nils T ^a   Thorlacius, Henrik ^b   Menger, Michael D ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Computed tomography; Imaging; Intravital fluorescence microscopy; Lung; Nanoparticles

Indexed keywords

COMPUTED TOMOGRAPHY; CONTRAST AGENT; DIAGNOSTIC APPLICATIONS; DRUG DELIVERY SYSTEM; GAMMA CAMERAS; HUMAN BODIES; IN-VIVO IMAGING; LUNG; NANOTOXICOLOGY; NEAR-INFRARED IMAGING; POTENTIAL IMPACTS; RESPIRATORY TRACT; XRAY IMAGING;

BIOLOGICAL ORGANS; CAMERAS; DRUG DELIVERY; FLUORESCENCE; FLUORESCENCE MICROSCOPY; GAMMA RAYS; IMAGING TECHNIQUES; INFRARED DEVICES; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; POSITRON EMISSION TOMOGRAPHY; THERMOGRAPHY (IMAGING);

COMPUTERIZED TOMOGRAPHY;

CONTRAST MEDIUM; NANOPARTICLE;

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; FLUORESCENCE MICROSCOPY; GAMMA CAMERA IMAGING; HUMAN; IN VIVO STUDY; LUNG; NEAR INFRARED IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; THORAX RADIOGRAPHY;

ANIMALS; DIAGNOSTIC IMAGING; HUMANS; LUMINESCENCE; LUNG; MAGNETIC RESONANCE IMAGING; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; POSITRON-EMISSION TOMOGRAPHY; SPECTROSCOPY, NEAR-INFRARED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 82255193873     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.02.010     Document Type: Review

References (87)

1. Mills NL, Donaldson K, Hadoke PW, Boon NA, MacNee W, Cassee FR, et al. Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med 2009, 6:36-44.
2. Damato G, Cecchi L, D'Amato M, Liccardi G Urban air pollution and climate change as environmental risk factors of respiratory allergy: an update. J Investig Allergol Clin Immunol 2010, 20:95-102.
3. Pope CA, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, et al. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 2004, 109:71-77.
4. Laden F, Schwartz J, Speizer FE, Dockery DW Reduction in fine particulate air pollution and mortality: extended follow-up of the Harvard Six Cities study. Am J Respir Crit Care Med 2006, 173:667-672.
5. Ostro B, Feng WY, Broadwin R, Green S, Lipsett M The effects of components of fine particulate air pollution on mortality in California: results from CALFINE. Environ Health Perspect 2007, 115:13-19.
6. Card JW, Zeldin DC, Bonner JC, Nestmann ER Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol Physiol 2008, 295:400-411.
7. Napierska D, Thomassen LC, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 2009, 5:846-853.
8. Duffin R, Tran CL, Clouter A, Brown DM, Macnee W, Stone V, et al. The Importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Ann Occup Hyg 2002, 46:242-245.
9. Li N, Xia T, Nel AE The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic Biol Med 2008, 44:1689-1699.
10. Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, et al. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol 2005, 2:10.
11. Churg A, Brauer M, del Carmen Avila-Casado M, Fortoul TI, Wright JL Chronic exposure to high levels of particulate air pollution and small airway remodeling. Environ Health Perspect 2003, 111:714-718.
12. Churg A, Wright JL Airway wall remodeling induced by occupational mineral dusts and air pollutant particles. Chest 2002, 122:306-309.
13. 2. Inhal Toxicol 2007, 19:205-212.
14. Peters A, von Klot S, Heier M, Trentinaglia I, Hormann A, Wichmann HE, et al. Exposure to traffic and the onset of myocardial infarction. N Engl J Med 2004, 351:1721-1730.
15. 2 nanocomposites used in sunscreen. Dispersion and fate of the degradation products in aqueous environment. Environ Pollut 2010, 158:3482-3489.
16. Generosi A, Rau JV, Rossi Albertini V, Paci B Crystallization process of carbonate substituted hydroxyapatite nanoparticles in toothpastes upon physiological conditions: an in situ time-resolved X-ray diffraction study. J Mater Sci Mater Med 2010, 21:445-450.
17. Tokatlian T, Segura T siRNA applications in nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010, 2:305-315.
18. Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 1999, 51:691-743.
19. Yu X, Zhang Y, Chen C, Yao Q, Li M Targeted drug delivery in pancreatic cancer. Biochim Biophys Acta 2010, 1805:97-104.
20. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006, 79:248-253.
21. Branca RT, Cleveland ZI, Fubara B, Kumar CS, Maronpot RR, Leuschner C, et al. Molecular MRI for sensitive and specific detection of lung metastases. Proc Natl Acad Sci USA 2010, 107:3693-3697.
22. Yong KT, Roy I, Ding H, Bergey EJ, Prasad PN Biocompatible near-infrared quantum dots as ultrasensitive probes for long-term in vivo imaging applications. Small 2009, 5:1997-2004.
23. Bridot JL, Faure AC, Laurent S, Riviere C, Billotey C, Hiba B, et al. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J Am Chem Soc 2007, 129:5076-5084.
24. Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, et al. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 2006, 3:11.
25. Koeneman BA, Zhang Y, Westerhoff P, Chen Y, Crittenden JC, Capco DG Toxicity and cellular responses of intestinal cells exposed to titanium dioxide. Cell Biol Toxicol 2010, 26:225-238.
26. Baroli B Penetration of nanoparticles and nanomaterials in the skin: fiction or reality?. J Pharm Sci 2010, 99:21-50.
27. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002, 65:1531-1543.
28. Li JJ, Muralikrishnan S, Ng CT, Yung LY, Bay BH Nanoparticle-induced pulmonary toxicity. Exp Biol Med (Maywood) 2010, 235:1025-1033.
29. Bur M, Henning A, Hein S, Schneider M, Lehr CM Inhalative nanomedicine-opportunities and challenges. Inhal Toxicol 2009, 21:137-143.
30. Namati E, Chon D, Thiesse J, Hoffman EA, de Ryk J, Ross A, et al. In vivo micro-CT lung imaging via a computer-controlled intermittent iso-pressure breath hold (IIBH) technique. Phys Med Biol 2006, 51:6061-6075.
31. Schmiedl UP, Krause W, Leike J, Sachse A CT blood pool enhancement in primates with lopromide-carrying liposomes containing soy phosphatidyl glycerol. Acad Radiol 1999, 6:164-169.
32. El-Gendy N, Aillon KL, Berkland C Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent. Int J Pharm 2010, 391:305-312.
33. Aillon KL, El-Gendy N, McDonald J, Dennis C, Berkland C Iodinated nanoclusters as an inhaled CT contrast agent for lung visualization. Mol Pharm 2010, 7:1274-1282.
34. McIntire GL, Bacon ER, Toner JL, Cornacoff JB, Losco PE, Illig KJ, et al. Pulmonary delivery of nanoparticles of insoluble, iodinated CT X-ray contrast agents to lung draining lymph nodes in dogs. J Pharm Sci 1998, 87:1466-1470.
35. Cai QY, Kim SH, Choi KS, Kim SY, Byun SJ, Kim KW, et al. Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice. Invest Radiol 2007, 42:797-806.
36. de Kemp RA, Epstein FH, Catana C, Tsui BM, Ritman EL Small-animal molecular imaging methods. J Nucl Med 2010, 51:18-32.
37. Townsend DW Positron emission tomography/computed tomography. Semin Nucl Med 2008, 38:152-166.
38. 64Cu-labeled polymer nanoparticles targeted to the lung endothelium. J Nucl Med 2008, 49:103-111.
39. Debbage P, Jaschke W Molecular imaging with nanoparticles: giant roles for dwarf actors. Histochem Cell Biol 2008, 130:845-875.
40. Welch MJ, Hawker CJ, Wooley KL The advantages of nanoparticles for PET. J Nucl Med 2009, 50:1743-1746.
41. Möller W, Meyer G, Scheuch G, Kreyling WG, Bennett WD Left-to-right asymmetry of aerosol deposition after shallow bolus inhalation depends on lung ventilation. J Aerosol Med Pulm Drug Deliv 2009, 22:333-339.
42. Möller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P, et al. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med 2008, 177:426-432.
43. Videira MA, Botelho MF, Santos AC, Gouveia LF, de Lima JJ, Almeida AJ Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J Drug Target 2002, 10:607-613.
44. Kreyling WG, Semmler-Behnke M, Seitz J, Scymczak W, Wenk A, Mayer P, et al. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol 2009, 21:55-60.
45. Palko HA, Fung JY, Louie AY Positron emission tomography: a novel technique for investigating the biodistribution and transport of nanoparticles. Inhal Toxicol 2010, 22:657-688.
46. Blamire AM The technology of MRI-the next 10 years?. Br J Radiol 2008, 81:601-617.
47. Kusakabe Y, Matsushita T, Honda S, Okada S, Murase K Using BOLD imaging to measure renal oxygenation dynamics in rats injected with diuretics. Magn Reson Med Sci 2010, 9:187-194.
48. 3He and proton imaging of magnetite biodistribution in a rat model of instilled nanoparticles. Magn Reson Med 2008, 59:1298-1303.
49. Peng XH, Qian X, Mao H, Wang AY, Chen ZG, Nie S, et al. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomed 2008, 3:311-321.
50. Wang YX, Hussain SM, Krestin GP Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001, 11:2319-2331.
51. Khemtong C, Kessinger CW, Ren J, Bey EA, Yang SG, Guthi JS, et al. In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles. Cancer Res 2009, 69:1651-1658.
52. Loebinger MR, Kyrtatos PG, Turmaine M, Price AN, Pankhurst Q, Lythgoe MF, et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 2009, 69:8862-8867.
53. le Masne de Chermont Q, Chaneac C, Seguin J, Pelle F, Maitrejean S, Jolivet JP, et al. Nanoprobes with near-infrared persistent luminescence for in vivo imaging. Proc Natl Acad Sci USA 2007, 104:9266-9271.
54. Zintchenko A, Susha AS, Concia M, Feldmann J, Wagner E, Rogach AL, et al. Drug nanocarriers labeled with near-infrared-emitting quantum dots (quantoplexes): imaging fast dynamics of distribution in living animals. Mol Ther 2009, 17:1849-1856.
55. Khullar O, Frangioni JV, Grinstaff M, Colson YL Image-guided sentinel lymph node mapping and nanotechnology-based nodal treatment in lung cancer using invisible near-infrared fluorescent light. Semin Thorac Cardiovasc Surg 2009, 21:309-315.
56. Maysinger D, Lovric J, Eisenberg A, Savic R Fate of micelles and quantum dots in cells. Eur J Pharm Biopharm 2007, 65:270-281.
57. Singhal S, Nie S, Wang MD Nanotechnology applications in surgical oncology. Annu Rev Med 2010, 61:359-373.
58. Surendiran A, Sandhiya S, Pradhan SC, Adithan C Novel applications of nanotechnology in medicine. Indian J Med Res 2009, 130:689-701.
59. Soltesz EG, Kim S, Laurence RG, DeGrand AM, Parungo CP, Dor DM, et al. Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. Ann Thorac Surg 2005, 79:269-277.
60. Menger MD, Lehr HA Scope and perspectives of intravital microscopy-bridge over from in vitro to in vivo. Immunol Today 1993, 14:519-522.
61. Fukumura D, Jain RK Imaging angiogenesis and the microenvironment. APMIS 2008, 116:695-715.
62. Roller J, Laschke MW, Scheuer C, Menger MD Heme oxygenase (HO)-1 protects from lipopolysaccharide (LPS)-mediated liver injury by inhibition of hepatic leukocyte accumulation and improvement of microvascular perfusion. Langenbecks Arch Surg 2010, 395:387-394.
63. Schwarzmaier SM, Kim SW, Trabold R, Plesnila N Temporal profile of thrombogenesis in the cerebral microcirculation after traumatic brain injury in mice. J Neurotrauma 2010, 27:121-130.
64. Laschke MW, Menger MD, Vollmar B Ovariectomy improves neovascularization and microcirculation of freely transplanted ovarian follicles. J Endocrinol 2002, 172:535-544.
65. Schramm R, Scheuer C, Yamauchi J, Vollmar B, Menger MD Heat shock preconditioning impairs revascularization of freely transplanted pancreatic islets. Transplantation 2002, 74:1544-1550.
66. Kollmar O, Rupertus K, Scheuer C, Junker B, Tilton B, Schilling MK, et al. Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia 2007, 9:862-870.
67. Laschke MW, Elitzsch A, Vollmar B, Menger MD In vivo analysis of angiogenesis in endometriosis-like lesions by intravital fluorescence microscopy. Fertil Steril 2005, 84:1199-1209.
68. Laschke MW, Dold S, Menger MD, Jeppsson B, Thorlacius H Platelet-dependent accumulation of leukocytes in sinusoids mediates hepatocellular damage in bile duct ligation-induced cholestasis. Br J Pharmacol 2008, 153:148-156.
69. Laschke MW, Häufel JM, Roller J, Schorr H, Menger MD Rapamycin, but not cyclosporine A, inhibits vascularization and incorporation of implanted surgical meshes. Transpl Int 2009, 22:654-662.
70. Roller J, Laschke MW, Sethi S, Herrmann M, Menger MD Prolene-Monocryl-composite meshes do not increase microvascular Staphylococcus aureus adherence and do not sensitize for leukocytic inflammation. Langenbecks Arch Surg 2008, 393:349-357.
71. Wanner GA, Mica L, Wanner-Schmid E, Kolb SA, Hentze H, Trentz O, et al. Inhibition of caspase activity prevents CD95-mediated hepatic microvascular perfusion failure and restores Kupffer cell clearance capacity. FASEB J 1999, 13:1239-1248.
72. Laschke MW, Häufel JM, Thorlacius H, Menger MD New experimental approach to study host tissue response to surgical mesh materials in vivo. J Biomed Mater Res A 2005, 74:696-704.
73. Vollmar B, Laschke MW, Rohan R, Koenig J, Menger MD In vivo imaging of physiological angiogenesis from immature to preovulatory ovarian follicles. Am J Pathol 2001, 159:1661-1670.
74. Huwer H, Nikoloudakis N, Rissland J, Vollmar B, Menger MD, Schäfers HJ In vivo analysis of microvascular injury after myocardial cryothermia. J Surg Res 1998, 79:1-7.
75. Khandoga A, Stoeger T, Khandoga AG, Bihari P, Karg E, Ettehadieh D, et al. Platelet adhesion and fibrinogen deposition in murine microvessels upon inhalation of nanosized carbon particles. J Thromb Haemost 2010, 8:1632-1640.
76. Rehberg M, Praetner M, Leite CF, Reichel CA, Bihari P, Mildner K, et al. Quantum dots modulate leukocyte adhesion and transmigration depending on their surface modification. Nano Lett 2010, 10:3656-3664.
77. Kuhnle GE, Leipfinger FH, Goetz AE Measurement of microhemodynamics in the ventilated rabbit lung by intravital fluorescence microscopy. J Appl Physiol 1993, 74:1462-1471.
78. Kuhnle GE, Kiefmann R, Sckell A, Kuebler WM, Groh J, Goetz AE Leukocyte sequestration in pulmonary microvessels and lung injury following systemic complement activation in rabbits. J Vasc Res 1999, 36:289-298.
79. McCormack DG, Mehta S, Tyml K, Scott JA, Potter R, Rohan M Pulmonary microvascular changes during sepsis: evaluation using intravital videomicroscopy. Microvasc Res 2000, 60:131-140.
80. Gebb SA, Graham JA, Hanger CC, Godbey PS, Capen RL, Doerschuk CM, et al. Sites of leukocyte sequestration in the pulmonary microcirculation. J Appl Physiol 1995, 79:493-497.
81. Tabuchi A, Mertens M, Kuppe H, Pries AR, Kuebler WM Intravital microscopy of the murine pulmonary microcirculation. J Appl Physiol 2008, 104:338-346.
82. Varghese HJ, MacKenzie LT, Groom AC, Ellis CG, Chambers AF, MacDonald IC Mapping of the functional microcirculation in vital organs using contrast-enhanced in vivo video microscopy. Am J Physiol Heart Circ Physiol 2005, 288:185-193.
83. Razavi HM, Wang le F, Weicker S, Rohan M, Law C, McCormack DG, et al. Pulmonary neutrophil infiltration in murine sepsis: role of inducible nitric oxide synthase. Am J Respir Crit Care Med 2004, 170:227-233.
84. Mitsuoka H, Unno N, Sakurai T, Kaneko H, Suzuki S, Konno H, et al. Pathophysiological role of endothelins in pulmonary microcirculatory disorders due to intestinal ischemia and reperfusion. J Surg Res 1999, 87:143-151.
85. Mitsuoka H, Sakurai T, Unno N, Kaneko H, Suzuki S, Nakamura S, et al. Intravital laser confocal microscopy of pulmonary edema resulting from intestinal ischemia-reperfusion injury in the rat. Crit Care Med 1999, 27:1862-1868.
86. Thiberville L, Salaün M, Lachkar S, Dominique S, Moreno-Swirc S, Vever-Bizet C, et al. Human in vivo fluorescence microimaging of the alveolar ducts and sacs during bronchoscopy. Eur Respir J 2009, 33:974-985.
87. Thiberville L, Salaün M, Lachkar S, Dominique S, Moreno-Swirc S, Vever-Bizet C, et al. Confocal fluorescence endomicroscopy of the human airways. Proc Am Thorac Soc 2009, 6:444-449.